Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,478,521 papers from all fields of science
Search
Sign In
Create Free Account
formal glycol
Known as:
1,3-dioxolane
, dioxolane
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Dioxolanes
Mutagens
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Synthesis and SAR studies of chiral non-racemic dexoxadrol analogues as uncompetitive NMDA receptor antagonists.
A. Banerjee
,
D. Schepmann
,
Jens Köhler
,
E. Würthwein
,
B. Wünsch
Bioorganic & Medicinal Chemistry
2010
Corpus ID: 41881554
2004
2004
Surface tension and density of mixtures of 1,3-dioxolane+alkanols at 298.15 K: analysis under the extended Langmuir model.
E. Calvo
,
M. Pintos
,
A. Amigo
,
Ramón Bravo
Journal of Colloid and Interface Science
2004
Corpus ID: 8642326
Highly Cited
2004
Highly Cited
2004
Identification of a Novel Class of Endoperoxides from Arachidonate Autoxidation*
H. Yin
,
J. Morrow
,
N. Porter
Journal of Biological Chemistry
2004
Corpus ID: 27746138
Free radical-initiated lipid autoxidation in low density lipoprotein (LDL) has been implicated in the pathogenesis of…
Expand
Highly Cited
2002
Highly Cited
2002
A specific and potent inhibitor of brassinosteroid biosynthesis possessing a dioxolane ring.
Katsuhiko Sekimata
,
Sun-Young Han
,
K. Yoneyama
,
Y. Takeuchi
,
S. Yoshida
,
T. Asami
Journal of Agricultural and Food Chemistry
2002
Corpus ID: 22488297
Screening for brassinosteroid biosynthesis inhibitors was performed to find azole derivatives that induced dwarfism, to resemble…
Expand
Highly Cited
2002
Highly Cited
2002
Dioxolane Guanosine, the Active Form of the Prodrug Diaminopurine Dioxolane, Is a Potent Inhibitor of Drug‐Resistant HIV‐1 Isolates From Patients for Whom Standard Nucleoside Therapy Fails
J. Mewshaw
,
Florence T. Myrick
,
+4 authors
K. Borroto-Esoda
Journal of Acquired Immune Deficiency Syndromes
2002
Corpus ID: 24370870
Summary: Amdoxovir ([‐]‐&bgr;‐D‐2,6‐diaminopurine dioxolane [DAPD]) is a nucleoside reverse transcriptase inhibitor (NRTI) with…
Expand
Highly Cited
2001
Highly Cited
2001
Remote dipole effects as a means to accelerate [Ru(amino alcohol)]-catalyzed transfer hydrogenation of ketones.
S. Nordin
,
P. Roth
,
T. Tarnai
,
D. Alonso
,
P. Brandt
,
P. Andersson
Chemistry
2001
Corpus ID: 34911890
A new generation of 2-aza-norbornyl amino alcohol ligands for the catalytic transfer hydrogenation reaction of aromatic ketones…
Expand
2000
2000
The new dioxolane, (-)-2'-deoxy-3'-oxacytidine (BCH-4556, troxacitabine), has activity against pancreatic human tumor xenografts.
S. Weitman
,
J. Marty
,
J. Jolivet
,
C. Locas
,
D. V. Von Hoff
Clinical Cancer Research
2000
Corpus ID: 23072287
There is a great need for new therapeutic agents for patients with advanced pancreatic cancer. The new dioxolane analogue…
Expand
Highly Cited
1997
Highly Cited
1997
Investigation of the Effects of the Structure and Chelate Size of Bis-oxazoline Ligands in the Asymmetric Copper-Catalyzed Cyclopropanation of Olefins: Design of a New Class of Ligands.
A. Bedekar
,
E. B. Koroleva
,
P. Andersson
Journal of Organic Chemistry
1997
Corpus ID: 25694372
A set of novel, C(2)-symmetric bis-oxazoline ligands has been synthesized by mounting two oxazoline rings onto an optically…
Expand
1988
1988
Chiral acetals in enantio- and diastereoselective substitution or elimination reactions
A. Alexakis*
,
P. Mangeney
,
+4 authors
J. Normant
1988
Corpus ID: 53709309
Abstract
1984
1984
Inhibition of carboxypeptidase A by aldehyde and ketone substrate analogues.
R. Galardy
,
Z. Kortylewicz
Biochemistry
1984
Corpus ID: 42484688
DL-2-Benzyl-3- formylpropanoic acid ( XIVb ) is a competitive inhibitor of carboxypeptidase A with an apparent Ki of 0.48 microM…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE